Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It.
Summary
Four vetted experts flagged this WSJ piece surfacing pharma C-suite skepticism toward AI health claims — a structurally important counterweight to the 'AI will cure cancer' consensus that has driven billions into healthcare AI investment and hiring in 2026; content unverified due to paywall blocking fetch.
Shared on Bluesky by 4 AI experts
-
This article is considerably more nuanced than the headline would suggest, but "We need AI because it will cure cancer" is a Silicon Valley talking point that has made me howl with rage for some time. www.wsj.com/tech/ai…
View on Bluesky → -
Alondra Nelson @alondra.bsky.social
"Executives leading the companies that discover new drugs say AI isn’t going to cure cancer anytime soon. They are dimming the hype around the technology’s use in drug research, saying human biology is too complicated ev…
View on Bluesky →
Originally reported by wsj.com
Read the original article →Original headline: Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It.